Bio-Rad Laboratories Debt to Equity Ratio 2010-2023 | BIO
Bio-Rad Laboratories Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-12-31 | $3.56B | $8.74B | 0.41 |
2023-09-30 | $3.48B | $8.42B | 0.41 |
2023-06-30 | $3.53B | $8.45B | 0.42 |
2023-03-31 | $3.90B | $9.76B | 0.40 |
2022-12-31 | $3.89B | $9.62B | 0.40 |
2022-09-30 | $3.61B | $8.45B | 0.43 |
2022-06-30 | $3.76B | $8.92B | 0.42 |
2022-03-31 | $4.19B | $10.18B | 0.41 |
2021-12-31 | $4.11B | $13.69B | 0.30 |
2021-09-30 | $4.62B | $15.33B | 0.30 |
2021-06-30 | $3.52B | $11.60B | 0.30 |
2021-03-31 | $3.32B | $10.61B | 0.31 |
2020-12-31 | $3.09B | $9.88B | 0.31 |
2020-09-30 | $3.20B | $8.83B | 0.36 |
2020-06-30 | $2.74B | $7.35B | 0.37 |
2020-03-31 | $2.39B | $6.29B | 0.38 |
2019-12-31 | $2.25B | $5.76B | 0.39 |
2019-09-30 | $2.05B | $5.13B | 0.40 |
2019-06-30 | $2.16B | $5.49B | 0.39 |
2019-03-31 | $2.00B | $4.86B | 0.41 |
2018-12-31 | $1.59B | $4.02B | 0.40 |
2018-09-30 | $1.82B | $4.90B | 0.37 |
2018-06-30 | $1.75B | $4.64B | 0.38 |
2018-03-31 | $1.73B | $4.49B | 0.39 |
2017-12-31 | $1.34B | $2.93B | 0.46 |
2017-09-30 | $1.34B | $2.85B | 0.47 |
2017-06-30 | $1.33B | $2.81B | 0.47 |
2017-03-31 | $1.25B | $2.71B | 0.46 |
2016-12-31 | $1.27B | $2.58B | 0.49 |
2016-09-30 | $1.32B | $2.70B | 0.49 |
2016-06-30 | $1.26B | $2.62B | 0.48 |
2016-03-31 | $1.21B | $2.54B | 0.48 |
2015-12-31 | $1.22B | $2.49B | 0.49 |
2015-09-30 | $1.24B | $2.43B | 0.51 |
2015-06-30 | $1.17B | $2.36B | 0.49 |
2015-03-31 | $1.13B | $2.20B | 0.51 |
2014-12-31 | $1.16B | $2.19B | 0.53 |
2014-09-30 | $1.21B | $2.18B | 0.56 |
2014-06-30 | $1.22B | $2.25B | 0.54 |
2014-03-31 | $1.21B | $2.23B | 0.54 |
2013-12-31 | $1.20B | $2.19B | 0.55 |
2013-09-30 | $1.16B | $2.12B | 0.54 |
2013-06-30 | $1.41B | $2.07B | 0.68 |
2013-03-31 | $1.43B | $2.03B | 0.70 |
2012-12-31 | $1.43B | $2.02B | 0.71 |
2012-09-30 | $1.37B | $1.94B | 0.71 |
2012-06-30 | $1.32B | $1.85B | 0.71 |
2012-03-31 | $1.35B | $1.84B | 0.73 |
2011-12-31 | $1.35B | $1.74B | 0.78 |
2011-09-30 | $1.28B | $1.69B | 0.75 |
2011-06-30 | $1.32B | $1.73B | 0.76 |
2011-03-31 | $1.30B | $1.61B | 0.80 |
2010-12-31 | $1.52B | $1.54B | 0.99 |
2010-09-30 | $1.25B | $1.43B | 0.88 |
2010-06-30 | $1.22B | $1.30B | 0.94 |
2010-03-31 | $1.25B | $1.30B | 0.96 |
2009-12-31 | $1.26B | $1.28B | 0.98 |
2009-09-30 | $1.25B | $1.23B | 1.02 |
2009-06-30 | $1.22B | $1.13B | 1.08 |
2009-03-31 | $0.90B | $1.06B | 0.85 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $7.989B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
Stryker (SYK) | United States | $124.672B | 30.91 |
Medtronic (MDT) | Ireland | $106.983B | 15.15 |
Boston Scientific (BSX) | United States | $99.792B | 33.18 |
EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
ResMed (RMD) | United States | $26.527B | 26.52 |
Terumo (TRUMY) | Japan | $25.252B | 35.66 |
Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
Baxter (BAX) | United States | $20.516B | 14.96 |
Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
Insulet (PODD) | United States | $11.513B | 60.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
Demant (WILYY) | Denmark | $9.853B | 0.00 |
BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
Haemonetics (HAE) | United States | $4.247B | 21.72 |
Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
Envista Holdings (NVST) | United States | $3.456B | 13.14 |
QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
Neogen (NEOG) | United States | $2.552B | 24.54 |
Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
ICU Medical (ICUI) | United States | $2.348B | 17.52 |
TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
Owens & Minor (OMI) | United States | $1.856B | 17.82 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
InMode (INMD) | Israel | $1.439B | 7.45 |
LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
Warby Parker (WRBY) | United States | $1.218B | 0.00 |
AtriCure (ATRC) | United States | $1.099B | 0.00 |
MacroGenics (MGNX) | United States | $0.964B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
Quanterix (QTRX) | United States | $0.623B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Jin Medical (ZJYL) | China | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
PetIQ (PETQ) | United States | $0.486B | 18.14 |
TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.422B | 25.82 |
Biote (BTMD) | United States | $0.414B | 3.94 |
OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
Surmodics (SRDX) | United States | $0.361B | 39.06 |
Zynex (ZYXI) | United States | $0.358B | 41.26 |
Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
Cerus (CERS) | United States | $0.306B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.178B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.80 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Safety Shot (SHOT) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.52 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |